dilevalol has been researched along with foscarnet in 2 studies
| Studies (dilevalol) | Trials (dilevalol) | Recent Studies (post-2010) (dilevalol) | Studies (foscarnet) | Trials (foscarnet) | Recent Studies (post-2010) (foscarnet) |
|---|---|---|---|---|---|
| 6 | 0 | 1 | 1,682 | 116 | 257 |
| Protein | Taxonomy | dilevalol (IC50) | foscarnet (IC50) |
|---|---|---|---|
| DNA polymerase catalytic subunit | Human herpesvirus 5 strain AD169 | 2.5 | |
| DNA polymerase catalytic subunit | Human herpesvirus 3 strain Dumas | 0.28 | |
| Reverse transcriptase/RNaseH | Human immunodeficiency virus 1 | 2.42 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
2 other study(ies) available for dilevalol and foscarnet
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |